p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia - PubMed (original) (raw)
p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia
G Gaidano et al. Proc Natl Acad Sci U S A. 1991.
Abstract
We have investigated the frequency of p53 mutations in B- and T-cell human lymphoid malignancies, including acute lymphoblastic leukemia, the major subtypes of non-Hodgkin lymphoma, and chronic lymphocytic leukemia. p53 exons 5-9 were studied by using genomic DNA from 197 primary tumors and 27 cell lines by single-strand conformation polymorphism analysis and by direct sequencing of PCR-amplified fragments. Mutations were found associated with (i) Burkitt lymphoma (9/27 biopsies; 17/27 cell lines) and its leukemic counterpart L3-type B-cell acute lymphoblastic leukemia (5/9), both of which also carry activated c-myc oncogenes, and (ii) B-cell chronic lymphocytic leukemia (6/40) and, in particular, its stage of progression known as Richter's transformation (3/7). Mutations were not found at any significant frequency in other types of non-Hodgkin lymphoma or acute lymphoblastic leukemia. In many cases, only the mutated allele was detectable, implying loss of the normal allele. These results suggest that (i) significant differences in the frequency of p53 mutations are present among subtypes of neoplasms derived from the same tissue; (ii) p53 may play a role in tumor progression in B-cell chronic lymphocytic leukemia; (iii) the presence of both p53 loss/inactivation and c-myc oncogene activation may be important in the pathogenesis of Burkitt lymphoma and its leukemic form L3-type B-cell acute lymphoblastic leukemia.
Similar articles
- Analysis of RAS oncogene mutations in human lymphoid malignancies.
Neri A, Knowles DM, Greco A, McCormick F, Dalla-Favera R. Neri A, et al. Proc Natl Acad Sci U S A. 1988 Dec;85(23):9268-72. doi: 10.1073/pnas.85.23.9268. Proc Natl Acad Sci U S A. 1988. PMID: 3057505 Free PMC article. - Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 cases.
Preudhomme C, Dervite I, Wattel E, Vanrumbeke M, Flactif M, Lai JL, Hecquet B, Coppin MC, Nelken B, Gosselin B, et al. Preudhomme C, et al. J Clin Oncol. 1995 Apr;13(4):812-20. doi: 10.1200/JCO.1995.13.4.812. J Clin Oncol. 1995. PMID: 7707106 - Mutations of the p53 gene in B-cell lymphoblastic acute leukemia: a report on 60 cases.
Fenaux P, Jonveaux P, Quiquandon I, Preudhomme C, Lai JL, Vanrumbeke M, Loucheux-Lefebvre MH, Bauters F, Berger R, Kerckaert JP. Fenaux P, et al. Leukemia. 1992 Jan;6(1):42-6. Leukemia. 1992. PMID: 1736012 - Coexistence of chronic myeloid leukemia and diffuse large B-cell lymphoma with antecedent chronic lymphocytic leukemia: a case report and review of the literature.
Abuelgasim KA, Rehan H, Alsubaie M, Al Atwi N, Al Balwi M, Alshieban S, Almughairi A. Abuelgasim KA, et al. J Med Case Rep. 2018 Mar 11;12(1):64. doi: 10.1186/s13256-018-1612-4. J Med Case Rep. 2018. PMID: 29524963 Free PMC article. Review. - Chromosomal translocations in leukaemia.
Gauwerky CE, Croce CM. Gauwerky CE, et al. Semin Cancer Biol. 1993 Dec;4(6):333-40. Semin Cancer Biol. 1993. PMID: 8142618 Review.
Cited by
- Single-cell transcriptomics of pediatric Burkitt lymphoma reveals intra-tumor heterogeneity and markers of therapy resistance.
Corinaldesi C, Holmes AB, Martire G, Tosato A, Rizzato D, Lovisa F, Gallingani I, Shen Q, Ferrone L, Harris M, Davies K, Molinaro L, Mortara U, Dei Tos AP, Ofori K, D'Amore ESG, Chiarle R, Ngan B, Carraro E, Pillon M, Hussein S, Bhagat G, Pizzi M, Mussolin L, Basso K. Corinaldesi C, et al. Leukemia. 2025 Jan;39(1):189-198. doi: 10.1038/s41375-024-02431-3. Epub 2024 Oct 18. Leukemia. 2025. PMID: 39424708 Free PMC article. - Comparison of familial and sporadic chronic lymphocytic leukaemia using high resolution array comparative genomic hybridization.
Setlur SR, Ihm C, Tchinda J, Shams S, Werner L, Cho EK, Thompson C, Phillips K, Rassenti LZ, Kipps TJ, Neuberg D, Freedman AS, Lee C, Brown JR. Setlur SR, et al. Br J Haematol. 2010 Nov;151(4):336-45. doi: 10.1111/j.1365-2141.2010.08341.x. Epub 2010 Aug 31. Br J Haematol. 2010. PMID: 20812997 Free PMC article. - Selective genetic analysis of p53 immunostain positive cells.
Phelps M, Wilkins BS, Jones DB. Phelps M, et al. Mol Pathol. 2000 Jun;53(3):159-61. doi: 10.1136/mp.53.3.159. Mol Pathol. 2000. PMID: 10897337 Free PMC article. - Human papillomavirus DNA and p53 status in stage IB bulky cervical cancer.
Chen CA, Chen TM, Wu CC, Chang CF, Hsieh CY. Chen CA, et al. J Cancer Res Clin Oncol. 1994;120(11):678-82. doi: 10.1007/BF01245381. J Cancer Res Clin Oncol. 1994. PMID: 7962045 - Alterations in the p53 and MDM-2 genes are infrequent in clinically localized, stage B prostate adenocarcinomas.
Ittmann M, Wieczorek R, Heller P, Dave A, Provet J, Krolewski J. Ittmann M, et al. Am J Pathol. 1994 Aug;145(2):287-93. Am J Pathol. 1994. PMID: 8053489 Free PMC article.
References
- Mol Cell Biol. 1986 May;6(5):1379-85 - PubMed
- Blood. 1986 Jul;68(1):113-8 - PubMed
- Proc Natl Acad Sci U S A. 1988 Dec;85(23):9268-72 - PubMed
- Gene. 1988 Oct 30;70(2):245-52 - PubMed
- Science. 1989 Apr 14;244(4901):217-21 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous